RARE CANCERS

Clinical trials for RARE CANCERS explained in plain language.

Never miss a new study

Get alerted when new RARE CANCERS trials appear

Sign up with your email to follow new studies for RARE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Cancer drug safety study tracks patients for years after initial treatment

Disease control Recruiting now

This study continues to monitor patients who have already completed previous cancer treatment studies with dabrafenib and/or trametinib. It tracks 100 patients with various cancers including melanoma and lung cancer to understand the long-term safety of these medications. The goa…

Matched conditions: RARE CANCERS

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

RARE CANCERS

Get alerted when new RARE CANCERS trials appear

Cancer drug safety study tracks patients for years after initial treatment